con: we are not yet ready to use vedolizumab in pediatric ibd
Published 9 years ago • 572 plays • Length 7:06Download video MP4
Download video MP3
Similar videos
-
8:32
pro: we are ready to use vedolizumab in pediatric ibd
-
10:25
con: anti-tnfs should be used before vedolizumab for moderate to severe ibd
-
8:25
vedolizumab as a treatment for crohn’s disease: efficacy and safety
-
12:04
pro: vedolizumab should be used before anti-tnfs for moderate to severe ibd
-
21:13
update on vedolizumab in ibd: what have we learned?
-
19:22
when can we use combination therapy for our pediatric ibd patients?
-
6:22
antibiotics and risk of new onset inflammatory bowel disease: a meta-analysis
-
10:33
pro: thiopurines still have a role in the management of pediatric ibd
-
21:01
transitional care in ibd: who is it for, and how should we do this?
-
21:36
keynote: evolution of disease management in ibd
-
41:15
targeting ibd: hitting the mark in today’s treatment landscape
-
18:07
expert perspectives: pediatric ibd
-
18:38
ibd and extra intestinal manifestations: treatment options
-
21:33
when can genetic testing be utilized in our ibd patients? pediatric ibd patients?
-
20:47
positioning inhibitors of lymphocyte trafficking
-
21:14
when and how to use immunomodulators and biologics in ibd
-
26:22
when and how to de-escalate therapy in ibd
-
44:04
case discussion: challenging cases in pediatric ibd
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators